Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: A randomized controlled trial

Diabetes Care

Volumn 33, Issue 6, 2010, Pages 1169-1172

  Logtenberg, Susan J ^a   Kleefstra, Nanne ^a,b   Houweling, Sebastiaan T ^a,b,c   Groenier, Klaas H ^d,e   Gans, Reinold O ^d,e   Bilo, Henk J ^a,d,e  

^a ISALA HOSPITAL   (Netherlands)

^b LANGERHANS MEDICAL RESEARCH GROUP   (Netherlands)

^c General Practice Sleeuwijk ^*  (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROSSOVER PROCEDURE; GLYCEMIC CONTROL; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; WORLD HEALTH ORGANIZATION; ECONOMICS; GLUCOSE BLOOD LEVEL; INFUSION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HUMANS; INFUSIONS, PARENTERAL; INFUSIONS, SUBCUTANEOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; PATIENT SATISFACTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 77956083796     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1758     Document Type: Article

References (12)

1. Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Gans RO, van Ballegooie E, Bilo HJ. Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial. Diabetes Care 2009;32:1372-1377
2. Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, The Health Institute, New England Medical Center, 1993
3. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, The Health Institute, New England Medical Center, 1994
4. World Health Organization, Regional Of- fice for Europe. Wellbeing measures in primary health care: the Depcare Project. Report on a WHO Meeting, Stockholm, 1998
5. Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 2003;12:85-91
6. Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004;78:131-140
7. Bradley C. Diabetes treatment satisfaction questionnaire. In Handbook of Psychology and Diabetes. Bradley C. Ed. Chur, Switzerland, Harwood Academic Publishers, 1994, p. 111-132
8. Oostenbrink JB, Bouwmans CA, Koopmanschap MA, Rutten FF. Manual for cost: methods and standard costs for economic evaluations in health care. Amstelveen, the Netherlands, Health Care Insurance Board, 2004 [in Dutch]
9. Guidance on the use of continuous subcutaneous insulin infusion for diabetes: Technology Appraisal Guidance No. 57. National Institute for Clinical Excellence (NICE), 2003. Available from http://www.nice.nhs.uk. Accessed 26 August 2008
10. Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 2004;8:1-171
11. Haveman JW, Logtenberg SJ, Kleefstra N, Groenier KH, Bilo HJ, Blomme AM. Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump. Langenbecks Arch Surg 2010;395:65-71
12. Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979;8:7-20